Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Impact of Early Oral Feeding on Post-Operative Morbidity After Esophagectomy: A Systematic Review and Meta-Analysis.

World journal of surgery·2026

Same author

Liver Transplantation Following Organ Donation After Medical Assistance in Dying: One Step Further.

Transplantation·2026

Same author

Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation.

Metabolism: clinical and experimental·2026

Same author

Correction: Extracellular Matrix-Guided Islet Cell Transplantation Results in Improved Glycemic Control in a NOD-SCID Mouse Model.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026

Same author

Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic β-cell function pretransplant.

The lancet. Diabetes & endocrinology·2026

Same author

Environmental sustainability in the operating room: perspectives and practice patterns of general surgeons in Canada.

Canadian journal of surgery. Journal canadien de chirurgie·2026

Search research articles

Related Experiment Video

Updated: Nov 1, 2025

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

Update on islet cell transplantation.

Kevin Verhoeff¹, Braulio A Marfil-Garza^1,2,3, A M James Shapiro⁴

¹Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Current Opinion in Organ Transplantation

|June 21, 2021

Summary

This summary is machine-generated.

Islet cell transplantation improves glycemic control for type 1 diabetes, reducing hypoglycemia risks. Advances in stem cell therapies offer a potential cure, overcoming tissue shortages and immunosuppression needs.

More Related Videos

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Published on: May 25, 2021

Related Experiment Videos

Last Updated: Nov 1, 2025

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Published on: May 25, 2021

Area of Science:

Endocrinology
Regenerative Medicine
Transplantation Immunology

Background:

Chronic diabetes complications strain healthcare systems globally.
Type 1 diabetes management presents challenges in glycemic control and hypoglycemia risks.
Islet cell transplantation is a promising therapeutic avenue for diabetes.

Purpose of the Study:

To review current clinical evidence and advancements in islet cell transplantation.
To discuss ongoing research and future challenges in the field.
To highlight the potential of islet cell transplantation as a curative therapy for diabetes.

Main Methods:

Review of recent clinical experience in islet cell transplantation.
Analysis of ongoing research in stem cell-based therapies.
Discussion of challenges including tissue source limitations and immunosuppression.

Main Results:

Demonstrated improvements in long-term glycemic control and insulin independence.
Emerging stem cell therapies show promise for personalized regenerative treatments.
Novel approaches aim to eliminate the need for chronic immunosuppression.

Conclusions:

Islet cell transplantation offers significant benefits for diabetes management.
Stem cell advancements may resolve tissue scarcity and immunosuppression issues.
Addressing access variability and ethical considerations is crucial for widespread adoption.